# Chest Pain Pilot Study

> **NCT00251901** · PHASE3 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 600 (—)

## Conditions studied

- Chest Pain
- Gastroesophageal Reflux

## Interventions

- **DRUG:** Esomeprazole

## Key facts

- **NCT ID:** NCT00251901
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-05
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 600 (—)
- **Last updated:** 2011-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00251901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00251901, "Chest Pain Pilot Study". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT00251901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*